- Home
- PED vs IPSC Comparison
PED vs IPSC Comparison
Compare PED & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- IPSC
- Stock Information
- Founded
- PED N/A
- IPSC 2019
- Country
- PED United States
- IPSC United States
- Employees
- PED N/A
- IPSC N/A
- Industry
- PED Oil & Gas Production
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- PED Energy
- IPSC Health Care
- Exchange
- PED Nasdaq
- IPSC Nasdaq
- Market Cap
- PED 54.5M
- IPSC 43.6M
- IPO Year
- PED N/A
- IPSC 2021
- Fundamental
- Price
- PED $0.60
- IPSC $0.50
- Analyst Decision
- PED Strong Buy
- IPSC Strong Buy
- Analyst Count
- PED 1
- IPSC 5
- Target Price
- PED $1.50
- IPSC $3.33
- AVG Volume (30 Days)
- PED 141.0K
- IPSC 539.5K
- Earning Date
- PED 11-13-2025
- IPSC 11-04-2025
- Dividend Yield
- PED N/A
- IPSC N/A
- EPS Growth
- PED 569.41
- IPSC N/A
- EPS
- PED 0.14
- IPSC N/A
- Revenue
- PED $35,334,000.00
- IPSC $114,128,000.00
- Revenue This Year
- PED N/A
- IPSC $1,589.94
- Revenue Next Year
- PED $17.41
- IPSC N/A
- P/E Ratio
- PED $4.29
- IPSC N/A
- Revenue Growth
- PED 3.93
- IPSC 5491.77
- 52 Week Low
- PED $0.47
- IPSC $0.34
- 52 Week High
- PED $1.04
- IPSC $1.86
- Technical
- Relative Strength Index (RSI)
- PED 48.81
- IPSC 43.65
- Support Level
- PED $0.59
- IPSC $0.48
- Resistance Level
- PED $0.62
- IPSC $0.52
- Average True Range (ATR)
- PED 0.03
- IPSC 0.02
- MACD
- PED 0.00
- IPSC 0.00
- Stochastic Oscillator
- PED 23.94
- IPSC 59.31
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.